Following the group discussions, judges re-score the entries to identify finalists and winners.
Following consideration of all submissions into PMEA, together with analysis of IQVIA data relating to company performance throughout 2022 and Q1 2023, judges will shortlist companies for interview.
Shortlisted companies will be contacted to arrange an interview via webinar, which will take place on Friday 3rd November 2023. No alternative date is available.
Finalists will be announced on www.pmlive.com and also in Pharmaceutical Market Europe.
All entrants will be notified by mid-October via email as to whether they are finalists.
You have full control of the information you provide. We understand the sensitivity of the material.
We have systems in place to ensure confidentiality at every stage of the judging process:
The results will be announced at the Awards on Wednesday 22 November 2023.
Coverage of PMEA results are reported in Pharmaceutical Market Europe magazine and on www.pmlive.com immediately after the event.
Published coverage is strictly limited to:
Entry deadline | 25 August 2023 |
Extended entry deadline | 1 September 2023* *additional fee applies |
Judging Day | 10 October 2023 |
Company/Team of the Year Interviews | 3 November 2023 |
PMEA Event | 22 November 2023 |